- At the end of 2012, more than one year after the smoking ban in cafés/bars, the local Foundation Against Cancer was not the only one to be satisfied by the ban on smoking in cafés/bars. In 2011, manufacturers of NRT smoking cessations aids despaired to see that Belgium was one of the last bastions where smoking was still allowed in cafés/bars and nightclubs. However, after years of waiting, the smoking ban became total in summer 2011. Against all expectations, according to the local Foundation Against Cancer, this measure was favourably welcomed by 59% of smokers, of which a higher number than usual jumped at the chance to quit smoking from autumn 2011– September is often a month for good resolutions.
- By acquiring the Nicorette brand in 2009, Janssen-Cilag became the clear leader in NRT smoking cessation aids. Whilst consumers clearly shifted towards more convenient smoking cessation aids in recent years, Nicorette concentrated with success on “modulable” formats such as Nicorette Gum and Nicorette Microtab Lemon. Nicorette’s strategy often bears fruit: it tries to recruit undecided and anxious smokers by helping them to reduce their consumption – a first step to increasing their self-confidence before stopping for good.
- In spite of the positive effects of the total ban of 2011on smoking in cafés/bars and the larger size of warnings on cigarette packs on consumers’ intention to quit smoking and on sales of NRT smoking cessation aids, Foundation Against Cancer and other experts are still not satisfied by the struggle against tobacco in Belgium. There are still too many incitements to smoke, such as a low local price. For instance, a bucket of shag tobacco (300 cigarettes) is three times less expensive in Belgium than in the UK. As a result, whilst the number of smokers remains stable in Belgium, in the region of 20% of the adult population in 2012, sales of cigarettes, and mainly shag tobacco, still progressed in 2012. Given that taxes and price increases by the Belgian government are too rare and too limited to have a significant psychological effect on smokers, sales of tobacco in Belgium are not likely to decline in the short term.
Samples (FAQs about samples):
Sample NRT Smoking Cessation Aids Market Research Report
Sample NRT Smoking Cessation Aids Data
Delivery: Files are delivered directly into your account within a few minutes of purchase.
Discover the latest market trends and uncover sources of future market growth for the NRT Smoking Cessation Aids industry in Belgium with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the NRT Smoking Cessation Aids industry in Belgium, our research will save you time and money while empowering you to make informed, profitable decisions.
The NRT Smoking Cessation Aids in Belgium market research report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volumes and values, company and brand market shares
- Five year forecasts of market trends and market growth
- Production, imports by origin, exports by destination
- Robust and transparent market research methodology, conducted in-country
Our market research reports answer questions such as:
- What is the market size of NRT Smoking Cessation Aids in Belgium?
- What are the major brands in Belgium?
- How have tobacco bans affected the sales of NRT Smoking Cessation Aids?
Why buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This industry report originates from Passport, our Consumer Health market research database.
Table of Contents
NRT Smoking Cessation Aids in Belgium - Category Analysis
- Table 1 Number of Smokers by Gender 2007-2012
- Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2007-2012
- Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2007-2012
- Table 4 NRT Gum Flavours: % Value Breakdown 2007-2012
- Table 5 NRT Smoking Cessation Aids Company Shares by Value 2008-2012
- Table 6 NRT Smoking Cessation Aids Brand Shares by Value 2009-2012
- Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2012-2017
- Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2012-2017
Consumer Health in Belgium - Industry Context
2012 is not a good year for consumer health
More repressive juridical context than deregulation
Multinationals are the most affected
Distribution remains under the control of chemists/pharmacies, despite some changes
Bleak prospects overall
KEY TRENDS AND DEVELOPMENTS
The outlook is clouding over for consumer health
Health and wellness called to order
Local authorities and experts do not help matters
Urgent need for calm
Local environment leaves more limited room for manoeuvre for multinationals
- Table 9 Consumer Expenditure on Health Goods and Medical Services 2007-2012
- Table 10 Life Expectancy at Birth 2007-2012
- Table 11 Sales of Consumer Health by Category: Value 2007-2012
- Table 12 Sales of Consumer Health by Category: % Value Growth 2007-2012
- Table 13 Consumer Health Company Shares 2008-2012
- Table 14 Consumer Health Brand Shares 2009-2012
- Table 15 Penetration of Private Label by Category 2007-2012
- Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
- Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
- Table 18 Forecast Sales of Consumer Health by Category: Value 2012-2017
- Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventative medicine
- Summary 1 OTC: Switches 2010-2012
- Summary 2 Research Sources